108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
Proximity-dependent biotinylation and uses thereof
#5402METHODS AND COMPOUNDS FOR GENE INSERTION INTO REPEATED CHROMOSOME REGIONS FOR MULTI-LOCUS ASSORTMENT AND DAISYFIELD DRIVES
#5403OPTIMIZED BINUCLEASE FUSIONS AND METHODS
#5404Engineered target specific nucleases
#5405Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
#5406Use of electrochemical devices or systems comprising redox-functionalized electrodes for bioseparation and biocatalysis
#5407Variant RNA-guided polypeptides and methods of use
#5408Methods of enhancing chromosomal homologous recombination
#5409TRANSPOSON SYSTEM AND METHODS OF USE
#5410Cell-permeable (CP)-Cas9 recombinant protein and uses thereof
#5411NANOPARTICLES FUNCTIONALIZED WITH GENE EDITING TOOLS AND RELATED METHODS
#5412STRUCTURE-GUIDED CHEMICAL MODIFICATION OF GUIDE RNA AND ITS APPLICATIONS
#5413CRISPR enzymes and systems
#5414CONDITIONAL ACTIVATION OF NUCLEIC ACID-GUIDED ENDONUCLEASES
#5415TARGETABLE PROTEINS FOR EPIGENETIC MODIFICATION AND METHODS FOR USE THEREOF
#5416Compositions and methods for the treatment of expanded repeat-associated disorders
#5417Method of determining target nucleic acid
#5418Methods and compositions for genome editing in non-dividing cells
#5419Methods, compositions and kits for increasing genome editing efficiency
#5420GENE KNOCKIN METHOD AND KIT FOR GENE KNOCKIN
#5421Genomic integration of DNA fragments in fungal host cells
#5422TARGETED GENOME OPTIMIZATION IN PLANTS
#5423Excision of retroviral nucleic acid sequences
#5424Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides
#5425LENTIVIRAL DELIVERY OF CRISPR/CAS CONSTRUCTS THAT CLEAVE GENES ESSENTIAL FOR HIV-1 INFECTION AND REPLICATION
#5426Evolved Cas9 proteins for gene editing
#5427Materials and methods for treatment of pain related disorders
#5428Method for the treatment of lysosomal storage diseases
#5429METHODS FOR VARIANT DETECTION
#5430CRISPR enzymes and systems
#5431Methods and compositions for regulation of transgene expression
#5432Method for producing N-acetylglucosamine by co-utilizing glucose and xylose based on CRISPRi
#5433Structure-engineered guide RNA
#5434Genome-Scale Engineering of Cells with Single Nucleotide Precision
#5435Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity
#5436TARGETED ENHANCED DNA DEMETHYLATION
#5437NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF
#5438Gene editing-based method of attenuating the beta-amyloid pathway
#5439Derivatisation of Insulin with Polysaccharides
#5440Cytoplasmic incompatibility factors and methods for controlling anthropods
#5441Genetically Edited Animal
#5442Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
#5443Means and methods to induce apomixis in plants
#5444PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES
#5445Compositions of and methods for in vitro viral genome engineering
#5446Polypeptide variants
#5447RNA targeting methods and compositions
#5448Method of monitoring RNase L activity
#5449Methods for treating cells containing fusion genes
#5450Anabolic Enhancers for Ameliorating Neurodegeneration
#5451Method for converting genome sequence of gram-positive bacterium by specifically converting nucleic acid base of targeted DNA sequence, and molecular complex used in same
#5452ENGINEERED CRISPR PROTEINS FOR COVALENT TAGGING NUCLEIC ACIDS
#5453COMPOSITIONS AND METHODS FOR CELL TARGETED HPV TREATMENT
#5454Microbial-based biosensors
#5455RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF
#5456CRISPR enabled multiplexed genome engineering
#5457CRISPR-CAS system for a filamentous fungal host cell
#5458Vector-free delivery of gene editing proteins and compositions to cells and tissues
#5459CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
#5460HIV CLINICAL PLAN
#5461COMPOSITIONS, SYSTEMS AND METHODS FOR PROGRAMMING IMMUNE CELL FUNCTION THROUGH TARGETED GENE REGULATION
#5462Methods and compositions for genomic editing
#5463Regulated biocircuit systems
#5464CAS9 proteins including ligand-dependent inteins
#5465Compositions and Methods of Delivering Treatments for Latent Viral Infections
#5466TRANSPOSON SYSTEM AND METHODS OF USE
#5467Manipulated immunoregulatory element and immunity altered thereby
#5468SINGLE GUIDE RNA/CRISPR/CAS9 SYSTEMS, AND METHODS OF USE THEREOF
#5469COMPOSITIONS AND METHODS FOR GENE EDITING
#5470Means and methods for modifying multiple alleles
#5471Improving a Microorganism by CRISPR-Inhibition
#5472Automated cell processing methods, modules, instruments, and systems
#5473Tuning CRISPR/Cas9 activity with chemically modified nucleotide substitutions
#5474DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF
#5475CRISPR-associated (CAS) protein
#5476Human induced pluripotent stem cells for high efficiency genetic engineering
#5477Production of itaconic acid
#5478Compositions and methods of modifying a plant genome to produce a MS9, MS22, MS26, or MS45 male-sterile plant
#5479Frequency-based modulation of diverse species in a nucleic acid library
#5480Method For Screening Target Specific Nuclease Using Multi-Target System Of On-Target And Off-Target And Use Thereof
#5481Regulation of gene expression using engineered nucleases
#5482CHIMERIC ANTIGEN RECEPTORS AND METHODS FOR USE
#5483Methods of transcription activator like effector assembly
#5484METHOD FOR PREPARING GENE KNOCK-IN CELLS
#5485Compositions and methods for treating CEP290 associated disease
#5486Using programmable DNA binding proteins to enhance targeted genome modification
#5487Using programmable DNA binding proteins to enhance targeted genome modification
#5488Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5489METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5490METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5491METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5492METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5493Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5494Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5495Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5496Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5497DNA-binding proteins and uses thereof
#5498CRISPR-related methods and compositions with governing gRNAs
#5499Treatment of HER2-Dependent Cancers by SORL1 Inhibition
#5500Automated cell processing methods, modules, instruments, and systems
#5501METHODS AND COMPOSITIONS RELATED TO BARCODE ASSISTED ANCESTRAL SPECIFIC EXPRESSION (BAASE)
#5502GENOME EDITING ENHANCERS
#5503Methods and compositions for genome editing via haploid induction
#5504RNA targeting methods and compositions
#5505COMPOSITIONS AND METHODS FOR INHIBITING ENDOGENOUS IMMUNOGLOBULIN GENES AND PRODUCING TRANSGENIC HUMAN IDIOTYPE ANTIBODIES
#5506DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF
#5507Treatment And/Or Prevention Of DNA-Triplet Repeat Diseases Or Disorders
#5508Compositions and methods for treating nonsteroidal anti-inflammatory drug (NSAID) associated coagulopathy, thrombocytopenia, glanzmann's thrombasthenia, and/or thrombosis
#5509GENE EDITING FOR IMMUNOLOGICAL DESTRUCTION OF NEOPLASIA
#5510Method for modifying target site in genome of eukaryotic cell, and method for detecting presence or absence of nucleic acid sequence to be detected at target site
#5511Methods for cleaving DNA and RNA molecules
#5512Enrichment of mutated cell free nucleic acids for cancer detection
#5513Methods of screening using barcoded libraries
#5514Self-Targeting Guide RNAs in CRISPR System
#5515NOVEL CAS9 SYSTEMS AND METHODS OF USE
#5516Cleaning compositions comprising enzymes
#5517Materials and methods for treatment of friedreich ataxia and other related disorders
#5518Method for detecting off-target sites of programmable nucleases in a genome
#5519Materials and methods for treatment of pain related disorders
#5520CRISPR-CAS SYSTEMS FOR ALTERING EXPRESSION OF GENE PRODUCTS
#5521Methods for modulating insect hygro- and/or thermosensation
#5522Materials and methods for treatment of autosomal dominant retinitis pigmentosa
#5523MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA
#5524Method for fragmenting DNA by nick translation
#5525METHOD FOR GENOME EDITING
#5526Methods and compositions for synthetic RNA endonucleases
#5527DETERMINATION OF RNA IN BLOOD OR OTHER FLUIDS
#5528Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disorders
#5529Therapeutic applications of CPF1-based genome editing
#5530COLICINS FOR TREATING BACTERIAL INFECTIONS
#5531Devices for CRISPR effector system based diagnostics
#5532Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using CRISPR/Cas system proteins
#5533CRISPR/Cas9 complex for genomic editing
#5534METHOD FOR MITIGATING METASTASIS
#5535Targeted in situ protein diversification by site directed DNA cleavage and repair
#5536Methods for treating or preventing HBV infection or HBV related diseases
#5537Methods and compositions for nucleoside triphosphate and ribonucleic acid production
#5538Engineered nucleases useful for treatment of hemophilia A
#5539Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells
#5540Particles coated with catalysts useful for splicing nucleic acids
#5541Genetic modification of cytokine inducible SH2-containing protein (CISH) gene
#5542Application of gene in improving photosynthesis of rice
#5543NOVEL GUIDE RNA/CAS ENDONUCLEASE SYSTEMS
#5544LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS
#5545GENETICALLY ENGINEERED CELLS AND METHODS OF MAKING THE SAME
#5546Combination chemotherapy for the treatment of cancer
#5547Method For In Vivo High-Throughput Evaluating Of RNA-Guided Nuclease Activity
#5548Cas9 fusion molecules, gene editing systems, and methods of use thereof
#5549CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING DUCHENNE MUSCULAR DYSTROPHY
#5550Methods for increasing efficiency of nuclease-mediated gene editing in stem cells
#5551CRISPR/CAS9-BASED REPRESSORS FOR SILENCING GENE TARGETS IN VIVO AND METHODS OF USE
#5552Detergent compositions comprising polypeptide variants
#5553Detergent compositions comprising polypeptide variants
#5554Method of dewatering post fermentation fluids
#5555Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cells
#5556METHODS FOR IMPROVED HOMOLOGOUS RECOMBINATION AND COMPOSITIONS THEREOF
#5557Therapeutic nuclease compositions and methods
#5558Transgenic T cell and chimeric antigen receptor T cell compositions and related methods
#5559Methods of treating mitochondrial disorders
#5560Immobilized RNPs for sequence-specific nucleic acid capture and digital detection
#5561METHODS AND COMPOSITIONS FOR NUCLEIC ACID DETECTION
#5562Methods and compositions for the targeted modification of a mouse ES cell genome
#5563EXCISION OF TRANSGENES IN GENETICALLY MODIFIED ORGANISMS
#5564SITE-SPECIFIC NUCLEASE SINGLE-CELL ASSAY TARGETING GENE REGULATORY ELEMENTS TO SILENCE GENE EXPRESSION
#5565Engineered nucleic-acid targeting nucleic acids
#5566Engineered Nucleases and Their Uses for Nucleic Acid Assembly
#5567Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
#5568Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5569Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5570Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5571Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5572Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5573Oncogenic Models Based on Delivery and Use of the CRISPR-Cas Systems, Vectors and Compositions
#5574Methods of making and using guide RNA for use with Cas9 systems
#5575FUSION PROTEIN FOR CRISPR/CAS SYSTEM AND COMPLEX COMPRISING THE SAME AND USES THEREOF
#5576Engineered CRISPR-Cas9 nucleases with altered PAM specificity
#5577RNA analysis by total hydrolysis and quantification of released nucleosides
#5578Engineered nucleic acid-targeting nucleic acids
#5579NOVEL CAS9 SYSTEMS AND METHODS OF USE
#5580NOVEL CAS SYSTEMS AND METHODS OF USE
#5581Peptide-mediated delivery of RNA-guided endonuclease into cells
#5582Method for using heat-resistant mismatch endonuclease
#5583ASSAY FOR THE REMOVAL OF METHYL-CYTOSINE RESIDUES FROM DNA
#5584Nanocapsule delivery system for ribonucleoproteins
#5585Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5586METHODS FOR GENOME EDITING IN ZYGOTES
#5587HIGH EFFICIENCY, HIGH THROUGHPUT GENERATION OF GENETICALLY MODIFIED NON-HUMAN MAMMALS BY MULTI-CYCLE ELECTROPORATION OF CAS9 PROTEIN
#5588METHODS AND COMPOSITIONS FOR VIRAL-BASED GENE EDITING IN PLANTS
#5589Fungal genome modification systems and methods of use
#5590Crispr enzymes and systems
#5591Coexpression of CAS9 and TREX2 for targeted mutagenesis
#5592Adenosine nucleobase editors and uses thereof
#5593RNA GUIDED ERADICATION OF VARICELLA ZOSTER VIRUS
#5594COMPOSITIONS FOR ERADICATING FLAVIVIRUS INFECTIONS IN SUBJECTS
#5595CRISPR-associated transposases and uses thereof
#5596System for site-specific modification of ALS gene using CRISPR-Cas9 system for production of herbicide-resistant rice and use of same
#5597Method for converting monocot plant genome sequence in which nucleic acid base in targeted DNA sequence is specifically converted, and molecular complex used therein
#5598RNA-directed DNA cleavage by the Cas9-crRNA complex
#5599Negative feedback regulation of HIV-1 by gene editing strategy
#5600Conditional CRISPR sgRNA expression
#5601Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction
#5602Methods of generating nucleic acid fragments
#5603Method for using heat-resistant mismatch endonuclease
#5604Methods for the treatment of corneal dystrophies
#5605CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION
#5606CRISPR enzymes and systems
#5607COMPOSITIONS AND METHODS FOR MODIFYING GENOMES
#5608CRISPRs WITH IMPROVED SPECIFICITY
#5609Engineered CRISPR-Cas9 nucleases
#5610Transposase-mediated imaging of the accessible genome
#5611Small molecules for dual function positron emission tomography (PET) and cell suicide switches
#5612Nano/micromotors for active and dynamic intracellular payload delivery
#5613METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5614Mitochondrial genome editing and regulation
#5615CRISPR-CPF1-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY
#5616GRNA FUSION MOLECULES, GENE EDITING SYSTEMS, AND METHODS OF USE THEREOF
#5617RNA targeting methods and compositions
#5618CATIONIC LIPID COMPOSITIONS FOR TISSUE-SPECIFIC DELIVERY
#5619Intracellular genomic transplant and methods of therapy
#5620Intracellular genomic transplant and methods of therapy
#5621CRISPR mediated recording of cellular events
#5622Compositions and methods for treating Huntington's disease and related disorders
#5623Molecular cell diary system
#5624Detergent composition comprising a DNase
#5625Methods and products for genetic engineering
#5626Isolation of extracellular vesicles (EVs) from red blood cells for gene therapy
#5627Intracellular genomic transplant and methods of therapy
#5628TALEN-based gene correction
#5629DETECTION OF NUCLEIC ACIDS
#5630NOVEL FAMILY OF RNA-PROGRAMMABLE ENDONUCLEASES AND THEIR USES IN GENOME EDITING AND OTHER APPLICATIONS
#5631Structure-guided chemical modification of guide RNA and its applications
#5632Crispr/Cas-Related Methods and Compositions for Treating Duchenne Muscular Dystrophy and Becker
#5633Compositions and methods for regulating gene expression for targeted mutagenesis
#5634Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
#5635Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
#5636Cas discrimination using tuned guide RNA
#5637CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#5638Method for producing DNA vectors from molecular bricks containing sequences of interest
#5639Engineered nucleic-acid targeting nucleic acids
#5640COMPOSITIONS AND METHODS COMPRISING SEQUENCES HAVING MEGANUCLEASE ACTIVITY
#5641Mutant Cas9 proteins
#5642TRACKING AND MANIPULATING CELLULAR RNA VIA NUCLEAR DELIVERY OF CRISPR/CAS9
#5643VECTORS AND SYSTEM FOR MODULATING GENE EXPRESSION
#5644Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease
#5645Methods and compositions for targeted single-stranded cleavage and targeted integration
#5646METHODS AND COMPOSITIONS FOR ASSESSING CRISPR/CAS-INDUCED RECOMBINATION WITH AN EXOGENOUS DONOR NUCLEIC ACID IN VIVO
#5647Cas-ready mouse embryonic stem cells and mice and uses thereof
#5648GENOME EDITING DETECTION
#5649Nuclease-mediated genome editing of primary cells and enrichment thereof
#5650Compositions and Methods to Treat Latent Viral Infections
#5651CRISPR/Cas9 complex for introducing a functional polypeptide into cells of blood cell lineage
#5652MICELLE BASED SYSTEM NUCLEASE ENCAPSULATION FOR IN-VIVO GENE EDITING
#5653METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#5654METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF
#5655Permanent epigenetic gene silencing
#5656Crispr enzyme mutations reducing off-target effects
#5657Mini-III RNases, Methods for Changing the Specificity of RNA Sequence Cleavage by Mini-III RNases, and Uses Thereof
#5658Controlling metabolism by substrate cofeeding
#5659Phosphonate-drug conjugates
#5660Genome Editing In Bacillus Host Cells
#5661METHOD FOR MODIFYING GENOME SEQUENCE THAT SPECIFICALLY CONVERTS NUCLEOBASE OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX USED IN SAID METHOD
#5662Methods and compositions for modulating gene expression
#5663METHODS FOR EXTENDING THE REPLICATIVE CAPACITY OF SOMATIC CELLS DURING AN EX VIVO CULTIVATION PROCESS
#5664EDITING MITOCHONDRIAL DNA
#5665REWIRING ABERRANT CANCER SIGNALING TO A THERAPEUTIC EFFECTOR RESPONSE WITH A SYNTHETIC TWO-COMPONENT SYSTEM
#5666PRIMARY HEMATOPOIETIC CELLS GENETICALLY ENGINEERED BY SLOW RELEASE OF NUCLEIC ACIDS USING NANOPARTICLES
#5667Gene editing of deep intronic mutations
#5668ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE
#5669CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#5670Real-time reporter systems for monitoring base editing
#5671METHODS AND COMPOSITION FOR THE PRODUCTION OF SEQUENCE SPECIFIC ANTIMICROBIALS
#5672Using nucleosome interacting protein domains to enhance targeted genome modification
#5673Method for using heat-resistant mismatch endonuclease
#5674Method for producing an animal comprising a germline genetic modification
#5675METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5676Compositions and methods for enhanced genome editing
#5677Compositions and Methods of Delivering Treatments for Latent Viral Infections
#5678Genome editing for treating glioblastoma
#5679Materials and methods for treatment of alpha-1 antitrypsin deficiency
#5680Enzyme Composition for DNA End Repair, Adenylation, Phosphorylation
#5681Variants of Cpf1 (Cas12a) with altered PAM specificity
#5682Crispr enzyme mutations reducing off-target effects
#5683Ubiquitin variants and uses therof as 53BP1 inhibitors
#5684Nucleic acid products and methods of administration thereof
#5685Tumor infiltrating lymphocytes and methods of therapy
#5686Test for predicting the ability of a salmonid to utilise dietary pigment
#5687Enzyme-pore constructs
#5688METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5689METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5690METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#5691METHODS AND KITS FOR CLONING-FREE GENOME EDITING
#5692CRISPR RNA targeting enzymes and systems and uses thereof
#5693CRISPR RNA targeting enzymes and systems and uses thereof
#5694In vitro cleavage of DNA using argonaute
#5695Method and composition for generating basal forebrain cholinergic neurons (BFCNS)
#5696Nucleotide-specific recognition sequences for designer TAL effectors
#5697Automated cell processing methods, modules, instruments, and systems
#5698Nucleic acid products and methods of administration thereof
#5699Nucleic acid products and methods of administration thereof
#5700Nucleic acid products and methods of administration thereof